Table of Contents Author Guidelines Submit a Manuscript
Canadian Respiratory Journal
Volume 2016, Article ID 1472823, 10 pages
http://dx.doi.org/10.1155/2016/1472823
Clinical Study

Dysregulation of Vascular Endothelial Progenitor Cells Lung-Homing in Subjects with COPD

1Department of Medicine, McMaster University, 1280 Main Street West, Hamilton, ON, Canada L8N 3Z5
2Firestone Institute for Respiratory Health, Asthma Research Group, St. Joseph’s Healthcare, 50 Charlton Avenue East, Hamilton, ON, Canada L8N 4A6

Received 27 October 2015; Revised 23 March 2016; Accepted 20 April 2016

Academic Editor: Simon G. Royce

Copyright © 2016 Brittany M. Salter et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. M. Fabbri and S. S. Hurd, “Global strategy for the diagnosis, management and prevention of COPD: 2003 update,” European Respiratory Journal, vol. 22, pp. 1–2, 2003. View at Publisher · View at Google Scholar
  2. P. J. Barnes, “Chronic obstructive pulmonary disease,” The New England Journal of Medicine, vol. 343, no. 4, pp. 269–280, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. V. I. Peinado, J. A. Barberà, J. Ramirez et al., “Endothelial dysfunction in pulmonary arteries of patients with mild COPD,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 274, no. 6, part 1, pp. L908–L913, 1998. View at Google Scholar
  4. S. Santos, V. I. Peinado, J. Ramírez et al., “Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD,” European Respiratory Journal, vol. 19, no. 4, pp. 632–638, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. J. A. Barberà, V. I. Peinado, and S. Santos, “Pulmonary hypertension in chronic obstructive pulmonary disease,” European Respiratory Journal, vol. 21, no. 5, pp. 892–905, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. V. N. Lama and S. H. Phan, “The extrapulmonary origin of fibroblasts: stem/progenitor cells and beyond,” Proceedings of the American Thoracic Society, vol. 3, no. 4, pp. 373–376, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Pizarro, J. García-Lucio, V. I. Peinado et al., “Circulating progenitor cells and vascular dysfunction in chronic obstructive pulmonary disease,” PLoS ONE, vol. 9, no. 8, Article ID e106163, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Sala, C. Villena, C. Balaguer et al., “Abnormal levels of circulating endothelial progenitor cells during exacerbations of COPD,” Lung, vol. 188, no. 4, pp. 331–338, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Palange, U. Testa, A. Huertas et al., “Circulating haemopoietic and endothelial progenitor cells are decreased in COPD,” European Respiratory Journal, vol. 27, no. 3, pp. 529–541, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. G. P. Fadini, M. Schiavon, M. Cantini et al., “Circulating progenitor cells are reduced in patients with severe lung disease,” Stem Cells, vol. 24, no. 7, pp. 1806–1813, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. T. P. Gavin, C. B. Robinson, R. C. Yeager, J. A. England, L. W. Nifong, and R. C. Hickner, “Angiogenic growth factor response to acute systemic exercise in human skeletal muscle,” Journal of Applied Physiology, vol. 96, no. 1, pp. 19–24, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Bussolino, M. F. Di Renzo, M. Ziche et al., “Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth,” Journal of Cell Biology, vol. 119, no. 3, pp. 629–641, 1992. View at Publisher · View at Google Scholar · View at Scopus
  13. L. E. Huang and H. F. Bunn, “Hypoxia-inducible factor and its biomedical relevance,” The Journal of Biological Chemistry, vol. 278, no. 22, pp. 19575–19578, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Sakamaki, K. Matsumoto, S. Mizuno, S. Miyoshi, H. Matsuda, and T. Nakamura, “Hepatocyte growth factor stimulates proliferation of respiratory epithelial cells during postpneumonectomy compensatory lung growth in mice,” American Journal of Respiratory Cell and Molecular Biology, vol. 26, no. 5, pp. 525–533, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. M. M. Pizzichini, T. A. Popov, A. Efthimiadis et al., “Spontaneous and induced sputum to measure indices of airway inflammation in asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 154, no. 4, pp. 866–869, 1996. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Sehmi, L. J. Wood, R. Watson et al., “Allergen-induced increases in IL-5 receptor α-subunit expression on bone marrow-derived CD34+ cells from asthmatic subjects: a novel marker of progenitor cell commitment towards eosinophilic differentiation,” Journal of Clinical Investigation, vol. 100, no. 10, pp. 2466–2475, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. S. G. Smith, A. Gugilla, M. Mukherjee et al., “Thymic stromal lymphopoietin and IL-33 modulate migration of hematopoietic progenitor cells in patients with allergic asthma,” The Journal of Allergy and Clinical Immunology, vol. 135, no. 6, pp. 1594–1602, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Voermans, W. R. Gerritsen, A. E. G. K. von dem Borne, and C. E. van der Schoot, “Increased migration of cord blood-derived CD34+ cells, as compared to bone marrow and mobilized peripheral blood CD34+ cells across uncoated or fibronectin-coated filters,” Experimental Hematology, vol. 27, no. 12, pp. 1806–1814, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. A. E. Catalli, J. V. Thomson, I. M. Babirad et al., “Modulation of β1-integrins on hemopoietic progenitor cells after allergen challenge in asthmatic subjects,” Journal of Allergy and Clinical Immunology, vol. 122, no. 4, pp. 803–810, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. N. M. Pandya, N. S. Dhalla, and D. D. Santani, “Angiogenesis-a new target for future therapy,” Vascular Pharmacology, vol. 44, no. 5, pp. 265–274, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. J. W. Wilson and S. Hii, “The importance of the airway microvasculature in asthma,” Current Opinion in Allergy and Clinical Immunology, vol. 6, no. 1, pp. 51–55, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Kawamoto, H.-C. Gwon, H. Iwaguro et al., “Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia,” Circulation, vol. 103, no. 5, pp. 634–637, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. A. A. Kocher, M. D. Schuster, M. J. Szabolcs et al., “Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function,” Nature Medicine, vol. 7, no. 4, pp. 430–436, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. B. Assmus, V. Schächinger, C. Teupe et al., “Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI),” Circulation, vol. 106, no. 24, pp. 3009–3017, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. D. H. Walter, K. Rittig, F. H. Bahlmann et al., “Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells,” Circulation, vol. 105, no. 25, pp. 3017–3024, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Werner, S. Junk, U. Laufs et al., “Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury,” Circulation Research, vol. 93, no. 2, pp. e17–e24, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Valgimigli, G. M. Rigolin, A. Fucili et al., “CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure,” Circulation, vol. 110, no. 10, pp. 1209–1212, 2004. View at Publisher · View at Google Scholar
  28. U. Ghani, A. Shuaib, A. Salam et al., “Endothelial progenitor cells during cerebrovascular disease,” Stroke, vol. 36, no. 1, pp. 151–153, 2005. View at Google Scholar
  29. C. J. Loomans, E. J. de Koning, F. J. Staal et al., “Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes,” Diabetes, vol. 53, no. 1, pp. 195–199, 2004. View at Publisher · View at Google Scholar
  30. O. M. Tepper, R. D. Galiano, J. M. Capla et al., “Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures,” Circulation, vol. 106, no. 22, pp. 2781–2786, 2002. View at Publisher · View at Google Scholar
  31. J. Grisar, D. Aletaha, C. W. Steiner et al., “Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis,” Circulation, vol. 111, no. 2, pp. 204–211, 2005. View at Publisher · View at Google Scholar
  32. K. de Groot, F. H. Bahlmann, J. Sowa et al., “Uremia causes endothelial progenitor cell deficiency,” Kidney International, vol. 66, no. 2, pp. 641–646, 2004. View at Publisher · View at Google Scholar
  33. J. H. Choi, K. L. Kim, W. Suh et al., “Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, pp. 1246–1252, 2004. View at Publisher · View at Google Scholar
  34. T. Eizawa, Y. Murakami, K. Matsui et al., “Circulating endothelial progenitor cells are reduced in hemodialysis patients,” Current Medical Research and Opinion, vol. 19, no. 7, pp. 627–633, 2003. View at Google Scholar
  35. A. A. Liebow, “Pulmonary emphysema with special reference to vascular changes,” American review of respiratory disease, vol. 80, no. 1, pp. 67–93, 1959. View at Google Scholar · View at Scopus
  36. I. K. Demedts, T. Demoor, K. R. Bracke, G. F. Joos, and G. G. Brusselle, “Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema,” Respiratory Research, vol. 7, article 53, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. N. F. Voelkel, C. Cool, L. Taraceviene-Stewart et al., “Janus face of vascular endothelial growth factor: the obligatory survival factor for lung vascular endothelium controls precapillary artery remodeling in severe pulmonary hypertension,” Critical Care Medicine, vol. 30, no. 5, pp. S251–S256, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. R. R. Foster, R. Hole, K. Anderson et al., “Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes,” American Journal of Physiology—Renal Physiology, vol. 284, no. 6, pp. F1263–F1273, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. Takahashi, Y. Izumi, M. Kohno, E. Ikeda, and H. Nomori, “Airway administration of vascular endothelial growth factor siRNAs induces transient airspace enlargement in mice,” International Journal of Medical Sciences, vol. 10, no. 12, pp. 1702–1714, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. M. M. Mura, B. Han, C. F. Andrade et al., “The early responses of VEGF and its receptors during acute lung injury: implication of VEGF in alveolar epithelial cell survival,” Critical Care, vol. 10, no. 5, article R130, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. W. J. Janssen, Z. X. Yunt, A. Muldrow et al., “Circulating hematopoietic progenitor cells are decreased in COPD,” COPD: Journal of Chronic Obstructive Pulmonary Disease, vol. 11, no. 3, pp. 277–289, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Suzuki, T. Betsuyaku, K. Nagai et al., “Decreased airway expression of vascular endothelial growth factor in cigarette smoke-induced emphysema in mice and COPD patients,” Inhalation Toxicology, vol. 20, no. 3, pp. 349–359, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. Kasahara, R. M. Tuder, C. D. Cool, D. A. Lynch, S. C. Flores, and N. F. Voelkel, “Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema,” American Journal of Respiratory and Critical Care Medicine, vol. 163, no. 3, pp. 737–744, 2001. View at Publisher · View at Google Scholar · View at Scopus
  44. X. Liu and C. Xie, “Human endothelial progenitor cells isolated from COPD patients are dysfunctional,” Molecular and Cellular Biochemistry, vol. 363, no. 1-2, pp. 53–63, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. V. I. Peinado, J. Ramírez, J. Roca, R. Rodriguez-Roisin, and J. A. Barberà, “Identification of vascular progenitor cells in pulmonary arteries of patients with chronic obstructive pulmonary disease,” American Journal of Respiratory Cell and Molecular Biology, vol. 34, no. 3, pp. 257–263, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. S. C. Dorman, A. Efthimiadis, I. Babirad et al., “Sputum CD34+IL-5Rα+ cells increase after allergen evidence for in situ eosinophilopoiesis,” American Journal of Respiratory and Critical Care Medicine, vol. 169, no. 5, pp. 573–577, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. R. Sehmi, K. Howie, D. R. Sutherland, W. Schragge, P. M. O'Byrne, and J. A. Denburg, “Increased levels of CD34+ hemopoietic progenitor cells in atopic subjects,” American Journal of Respiratory Cell and Molecular Biology, vol. 15, no. 5, pp. 645–654, 1996. View at Publisher · View at Google Scholar · View at Scopus
  48. E.-K. Kim, J.-H. Lee, H.-C. Jeong et al., “Impaired colony-forming capacity of circulating endothelial progenitor cells in patients with emphysema,” The Tohoku Journal of Experimental Medicine, vol. 227, no. 4, pp. 321–331, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. M. C. Yoder, “Endothelial progenitor cell: a blood cell by many other names may serve similar functions,” Journal of Molecular Medicine, vol. 91, no. 3, pp. 285–295, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Oliveras, M. J. Soler, O. M. Martínez-Estrada et al., “Endothelial progenitor cells are reduced in refractory hypertension,” Journal of Human Hypertension, vol. 22, no. 3, pp. 183–190, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. J. M. Hill, G. Zalos, J. P. J. Halcox et al., “Circulating endothelial progenitor cells, vascular function, and cardiovascular risk,” The New England Journal of Medicine, vol. 348, no. 7, pp. 593–600, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. M. Vasa, S. Fichtlscherer, A. Aicher et al., “Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease,” Circulation Research, vol. 89, no. 1, pp. E1–E7, 2001. View at Google Scholar · View at Scopus
  53. C. J. M. Loomans, R. Van Haperen, J. M. Duijs et al., “Differentiation of bone marrow-derived endothelial progenitor cells is shifted into a proinflammatory phenotype by hyperglycemia,” Molecular Medicine, vol. 15, no. 5-6, pp. 152–159, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. G. P. Fadini, P. Madeddu, J. Waltenberger, and P. Fiorina, “Vascular stem and progenitor cells in diabetic complications,” Experimental Diabetes Research, vol. 2012, Article ID 580343, 2 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. M. V. Lopez Varela, M. Montes De Oca, R. J. Halbert et al., “Sex-related differences in COPD in five Latin American cities: the PLATINO study,” European Respiratory Journal, vol. 36, no. 5, pp. 1034–1041, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. I.-C. Sørheim, A. Johannessen, A. Gulsvik, P. S. Bakke, E. K. Silverman, and D. L. DeMeo, “Gender differences in COPD: are women more susceptible to smoking effects than men?” Thorax, vol. 65, no. 6, pp. 480–485, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. G. L. Hoetzer, G. P. Van Guilder, H. M. Irmiger, R. S. Keith, B. L. Stauffer, and C. A. DeSouza, “Aging, exercise, and endothelial progenitor cell clonogenic and migratory capacity in men,” Journal of Applied Physiology, vol. 102, no. 3, pp. 847–852, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. T. Kondo, M. Hayashi, K. Takeshita et al., “Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 8, pp. 1442–1447, 2004. View at Publisher · View at Google Scholar · View at Scopus
  59. M. Brittan, M. M. Hoogenboom, G. J. Padfield et al., “Endothelial progenitor cells in patients with chronic obstructive pulmonary disease,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 305, no. 12, pp. L964–L969, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. S. É. Michaud, S. Dussault, P. Haddad, J. Groleau, and A. Rivard, “Circulating endothelial progenitor cells from healthy smokers exhibit impaired functional activities,” Atherosclerosis, vol. 187, no. 2, pp. 423–432, 2006. View at Publisher · View at Google Scholar · View at Scopus